source
- Global scale, regional proximity and unified quality systems boost biologics supply resilienceThe piece explains that creating resilient biomanufacturing supply networks starts with leveraging a global scale of production to spread risk and capacity. It adds that locating facilities closer…
- Beam Therapeutics' base-edited sickle cell therapy shows success in Phase 1/2 trialBeam Therapeutics announced on Tuesday that its base-edited gene therapy for sickle cell disease met its primary endpoints in a Phase 1/2 study. The trial demonstrated that a single administration…